Jyong Biotech (MENS) Shares Outstanding (2024 - 2025)
Jyong Biotech (MENS) posted Shares Outstanding (Entity) of $76.0 million for Q4 2025, up 3.63% on a QoQ basis from $73.4 million in Q4 2024, and up 3.63% year-over-year from $73.4 million in Q4 2024.
Analysis
Jyong Biotech (MENS) Shares Outstanding (2024 - 2025) Analysis & Trends
Jyong Biotech has reported Shares Outstanding (Entity) for 2 years, with the latest figure at $76.0 million in Q4 2025.
- On a quarterly basis, Shares Outstanding (Entity) rose 3.63% year-over-year to $76.0 million in Q4 2025; TTM through Dec 2025 was $76.0 million, a 3.63% increase from a year earlier, with the FY2025 full-year figure at $76.0 million, up 3.63% from the prior year.
- Shares Outstanding (Entity) was $76.0 million for Q4 2025 at Jyong Biotech, up from $73.4 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $76.0 million in Q4 2025, with the low at $73.4 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 5.70 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 210.89 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 200.38 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 42.60 Mn |
| 10 | Jyong Biotech | 159.89 Mn | 159.89 Mn | - | 73.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 73.01 Mn |
| Jun 30, 2025 | 71.57 Mn |
| Dec 31, 2024 | 71.57 Mn |